Press Releases

Current Articles | Categories | Search | Syndication

14 January 2015  Joanne Hunter
VersaCell X3: Enhanced workflow within a small footprint
By Joanne Hunter @ 09:16 :: 196 Views

Siemens Healthcare Diagnostics has recently unveiled its latest advancements in compact robotic laboratory automation solutions. The VersaCell® X3 consolidates sample management for chemistry and immunoassay testing. The system assists laboratories to achieve some of the workflow benefits of automation without the space or budget considerations associated with a track-based solution. Siemens has already completed the first UK installation. 

Read More

12 December 2014  Joanne Hunter
Abbott 's Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe
By Joanne Hunter @ 08:50 :: 344 Views

- IRIDICA has the potential to change how pathogens that cause serious infections, such as sepsis and pneumonia, are detected and identified

- May provide doctors with information needed to start treating those who are critically ill with appropriate therapies sooner

- May help reduce the use of broad-spectrum antibiotics, a leading cause of antibiotic resistance

Read More

09 December 2014  Joanne Hunter
Mast Group Ltd wins Outstanding Achievement accolade at the Medilink Awards
By Joanne Hunter @ 08:42 :: 287 Views

Bootle-based Mast Group has won the Medical Engineers Outstanding Achievement Award at the Medilink North West Awards.

Read More

05 December 2014  Joanne Hunter
Hologic Enters the Viral Load Market with CE Mark Certification for the Aptima HIV-1 Viral Load Test
By Joanne Hunter @ 10:18 :: 343 Views

The new assay is certified for both diagnosis and viral load monitoring on the Panther system

Bedford, Mass., Dec. 1, 2014 -- Hologic, Inc. (NASDAQ: HOLX), today announced CE mark certification for its new Aptima HIV-1 Quant Dx assay for use on the Company’s Panther system. The Aptima HIV-1 Quant Dx assay, employing Hologic proprietary real-time transcription-mediated amplification (Real-time TMA) technology, is the first HIV viral load assay with a dual claim for both diagnosis and treatment monitoring. This milestone marks Hologic’s entry into the viral load market.

Read More

28 November 2014  Joanne Hunter
By Joanne Hunter @ 13:52 :: 366 Views

28 November, 2014: The board is pleased to announce that the further assessment of an additional 20 cases of pancreatic cancer using SysQuant® has recently been completed. The results validate the findings from the first 12 cases that were published earlier this year in PLOS ONE. As well as potential new drug targets, a key outcome of this study is a set of new biomarkers predicting the likelihood and timescale of tumour recurrence after surgery and the ability to match patients to individual drug treatments. Proteome has already filed patent applications around these markers.

Read More

20 November 2014  Joanne Hunter
Fast, Accurate ID of MRSA by detecting mecA gene mRNA New mecA XpressFISH
By Joanne Hunter @ 11:44 :: 372 Views

The new AdvanDx mecA XpressFISH assay, exclusively available in the UK from Alpha Laboratories, is the first and only molecular assay that detects the active resistance gene (mecA) from positive Staphylococcus aureus blood cultures.

Read More

17 November 2014  Joanne Hunter
By Joanne Hunter @ 16:08 :: 373 Views

The successful development of new platform technology for the rapid point of care (POC) diagnosis of flu and other respiratory conditions has widespread potential for the detection of a wide range of other infectious diseases.

Read More

06 November 2014  Joanne Hunter
EKF Molecular to Exhibit at AMP 2014
By Joanne Hunter @ 12:16 :: 347 Views

Cardiff, UK – 6 November 2014 – EKF Diagnostics, the global diagnostics company, has announced that senior executives from EKF Molecular Diagnostics including CEO, Andrew Webb, will be present at the Association for Molecular Pathology (AMP) annual meeting on booth 1028, to discuss with delegates the predicted outcomes of its research collaboration with Massachusetts General Hospital (MGH). Under the two year agreement, EKF Molecular will develop high sensitivity assays for the detection of genetic variation in circulating tumour cells (CTCs), using its PointMan™ DNA enrichment technology. MGH will clinically validate PointMan in lung, breast and skin cancer, using CTCs isolated from a patient’s blood by MGH’s CTC-Chip instrument.

Read More

29 October 2014  Joanne Hunter
By Joanne Hunter @ 12:18 :: 403 Views

Randox Laboratories has launched a third party multi-analyte haematology control; the most comprehensive haematology quality control (QC) solution on the market to date.

Read More

29 October 2014  Joanne Hunter
Key opinion leaders provide an insight into best practice in acute cardiac care
By Joanne Hunter @ 10:46 :: 370 Views

Radiometer, a leading provider of technologically advanced acute care testing solutions, is pleased to announce the publication of Excellence in acute cardiac care, a supplement to the European Heart Journal: Acute Cardiovascular Care.

Read More

Previous Page | Next Page